Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: EMU2 who wrote (49597)	1/22/2019 3:58:10 PM
From: kdd999	Read Replies (1) of 63307

Emu, if you google on press release crl fda ( i think that is what i did), it pulls up lots of companies that got crls that the ceo said was a shock to them. It is not that unique. According to one researcher, about 50% of crls are clinical result related and 50% process related. (I gave the link earlier). Another researcher found that press releases never conveyed complete info. The fda website discussed that fda had been asked to provide crl to public, but they dont do it because of confidentiality,etc. I.e, protect property of the corporations paying them vs protect patients who would like to know the history of what is being shoved into their bodies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next